Literature DB >> 26585906

DHA-induced stress response in human colon cancer cells - Focus on oxidative stress and autophagy.

Kristine Pettersen1, Vivi Talstad Monsen2, Caroline Hild Hakvåg Pettersen2, Hilde Bremseth Overland3, Grete Pettersen2, Helle Samdal2, Almaz Nigatu Tesfahun2, Anne Gøril Lundemo2, Geir Bjørkøy4, Svanhild A Schønberg5.   

Abstract

Polyunsaturated fatty acids (PUFAs) are important constituents of the diet and health benefits of omega-3/n-3 PUFAs, especially eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3) have been well documented in relation to several diseases. Increasing evidence suggests that n-3 PUFAs may have anticancer activity and improve the effect of conventional cancer therapy. The mechanisms behind these effects are still unclear and need to be elucidated. We have examined the DHA-induced stress response in two human colon cancer cell lines, SW620 and Caco-2. SW620 cells are growth-inhibited at early time points by DHA, while the growth of Caco-2 cells almost remains unaffected by the same treatment. Gene expression analysis of SW620 cells treated with DHA revealed changes at early time points; transcripts involved in oxidative stress and autophagy were among the first to be differentially expressed. We find that oxidative stress is induced in both cell lines, although at different time points and to different extent. DHA induced nuclear translocation of the oxidative stress sensor NFE2L2 in both cell lines, indicating an induction of an anti-oxidative response. However, vitamin E did not counteract ROS-production or the translocation of NFE2L2 to the nucleus. Neither vitamin E nor the antioxidants butylated hydoxyanisole (BHA) and butylated hydoxytoluene (BHT) did affect the growth inhibition in SW620 cells after DHA-treatment. Also, siRNA-mediated down-regulation of NFE2L2 did not sensitize SW620 and Caco-2 cells to DHA. These results indicate that oxidative stress response is not the cause of DHA-induced cytotoxicity in SW620 cells. Using biochemical and imaging based functional assays, we found a low basal level of autophagy and no increase in autophagic flux after adding DHA to the SW620 cells. However, Caco-2 cells displayed a higher level of autophagy, both in the absence and presence of DHA. Inhibition of autophagy by siRNA mediated knock down of ATG5 and ATG7 sensitized both SW620 and Caco-2 cells to DHA. Stimulation of autophagy by rapamycin in SW620 and Caco-2 cells resulted in decreased DHA-sensitivity and inhibition of autophagy in Caco-2 cells by chloroquine resulted in increased DHA-sensitivity. These results suggest that autophagy is important for the DHA sensitivity of colon cancer cells and imply possible therapeutic effects of this fatty acid against cancer cells with low autophagy.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Colon cancer; DHA; NFE2L2; Oxidative stress; n−3 PUFA

Mesh:

Substances:

Year:  2015        PMID: 26585906     DOI: 10.1016/j.freeradbiomed.2015.11.018

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  17 in total

1.  SQSTM1/p62 is involved in docosahexaenoic acid-induced cellular autophagy in glioblastoma cell lines.

Authors:  Xuefeng Tan; Linqing Zou; Jianbing Qin; Donglin Xia; Youlang Zhou; Guohua Jin; Zhuang Jiang; Haoming Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-08-19       Impact factor: 2.416

2.  Galantamine inhibits β-amyloid-induced cytostatic autophagy in PC12 cells through decreasing ROS production.

Authors:  Sheng Jiang; Ye Zhao; Tao Zhang; Jingbin Lan; Jing Yang; Longhui Yuan; Qiyu Zhang; Kejian Pan; Kun Zhang
Journal:  Cell Prolif       Date:  2018-01-01       Impact factor: 6.831

3.  Effects of DHA on Hippocampal Autophagy and Lysosome Function After Traumatic Brain Injury.

Authors:  Yan Yin; Eric Li; George Sun; Hong Q Yan; Lesley M Foley; Liwia A Andrzejczuk; Insiya Y Attarwala; T Kevin Hitchens; Kirill Kiselyov; C Edward Dixon; Dandan Sun
Journal:  Mol Neurobiol       Date:  2017-04-01       Impact factor: 5.590

4.  Membrane Disordering by Eicosapentaenoic Acid in B Lymphomas Is Reduced by Elongation to Docosapentaenoic Acid as Revealed with Solid-State Nuclear Magnetic Resonance Spectroscopy of Model Membranes.

Authors:  Mitchell Harris; Jacob J Kinnun; Rasagna Kosaraju; Xiaoling Leng; Stephen R Wassall; Saame Raza Shaikh
Journal:  J Nutr       Date:  2016-06-15       Impact factor: 4.798

5.  Free docosahexaenoic acid promotes ferroptotic cell death via lipoxygenase dependent and independent pathways in cancer cells.

Authors:  Kai Shan; Ninghan Feng; Doudou Zhu; Hongyan Qu; Guoling Fu; Jiaqi Li; Jing Cui; Heyan Chen; Rong Wang; Yumin Qi; Yong Q Chen
Journal:  Eur J Nutr       Date:  2022-07-09       Impact factor: 5.614

6.  Relationship of serum polyunsaturated fatty acids with cytokines in colorectal cancer.

Authors:  He-Jin Jia; Peng-Jun Zhang; Yu-Lan Liu; Chao-Guang Jiang; Xu Zhu; Ya-Ping Tian
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

Review 7.  Protective Effects of ω-3 PUFA in Anthracycline-Induced Cardiotoxicity: A Critical Review.

Authors:  Simona Serini; Renata Ottes Vasconcelos; Renata Nascimento Gomes; Gabriella Calviello
Journal:  Int J Mol Sci       Date:  2017-12-12       Impact factor: 5.923

Review 8.  The NRF2 transcription factor plays a dual role in colorectal cancer: A systematic review.

Authors:  C Gonzalez-Donquiles; J Alonso-Molero; T Fernandez-Villa; L Vilorio-Marqués; A J Molina; V Martín
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

Review 9.  Docosahexaenoic Acid Induces Oxidative DNA Damage and Apoptosis, and Enhances the Chemosensitivity of Cancer Cells.

Authors:  Eun Ah Song; Hyeyoung Kim
Journal:  Int J Mol Sci       Date:  2016-08-03       Impact factor: 5.923

10.  Combination of Fe/Cu -chelators and docosahexaenoic acid: an exploration for the treatment of colorectal cancer.

Authors:  Nanhui Yu; Hong Zhu; Yuan Yang; Yiming Tao; Fengbo Tan; Qian Pei; Yuan Zhou; Xiangping Song; Qiurong Tan; Haiping Pei
Journal:  Oncotarget       Date:  2017-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.